A single-dose gene replacement therapy is found to improve movement ability in children over 2 years of age and teenagers ...
Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise awareness and deepen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback